From: 13/07/2017 to: 18/07/2017 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 15/07/2017 to: 15/07/2017 Breast Cancer in Young Women: Joint DFCI-ESO Symposium, Boston, US                                        From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 18/10/2017 to: 18/10/2017 ESO Breast Cancer Observatory, Tehran, Iran                                        From: 27/10/2017 to: 28/10/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 15/12/2017 to: 18/12/2017 6th Arab and Southern European Countries Masterclass in Clinical Oncology, Limassol, Cyprus                                        From: 24/03/2018 to: 29/03/2018 17th ESO-ESMO Masterclass in Clinical Oncology, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 18/04/2018 to: 22/04/2018 4th ESO-ESMO Latin-American Masterclass in Clinical Oncology, Mexico City, Mexico                                        From: 6/10/2018 to: 8/10/2018 4th ESO-ESMO Breast Cancer in Young Women International Conference, Lugano, Switzerland

Editorial board


Chairmen

James O. Armitage, University of Nebraska Medical Center, Omaha, US
Manuela Bergmann, Schwabing Clinic, Munich, DE
Franco Cavalli, European School of Oncology (ESO) and Oncology Institute of Southern Switzerland, Bellinzona, CH
Stephan Stilgenbauer, Ulm University Hospital, DE


Scientific Directors

Elias Campo, University of Barcelona, Barcelona, ES
Bertrand Coiffier, Centre Hospitalier Lyon Sud, Pierre Bénite, FR
Andreas Engert, University Clinic Cologne, Cologne, DE
Massimo Federico, University of Modena and Reggio Emilia, Modena, IT
Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara, IT
Randy Gascoyne, B.C. Cancer Agency, Vancouver, CA
Mary Gospodarowicz, Princess Margaret Hospital - University of Toronto, Toronto, CA
Anton Hagenbeek, University of Amsterdam - Academic Medical Centre, Amsterdam, NL
T. Andrew Lister, St. Bartholomew's Hospital, London, UK
Julie M. Vose, University of Nebraska Medical Center, Omaha, US
Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, CH


Lecturers: Seminar 1

Lecturers to be confirmed


Lecturers: Module 1

Francesco Bertoni, IOSI - Oncology Institute of Southern Switzerland, Bellinzona, CH
George A. Calin, The RNA Interference and Non-codingRNA Center at MD Anderson Cancer Center, Houston, TX, US
Pedro Farinha, Centro Hospitalar Lisboa Central & Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, PT
Ralf Küppers, University of Duisburg-Essen, Essen, DE
Laura Pasqualucci, Institute for Cancer Genetics and Dpt of Pathology and Cell Biology, Columbia University, New York, NY, US
Daniel Mertens, University Hospital Ulm, Ulm, DE
Ryan Morin, Simon Fraser University and Scientist, British Columbia Cancer Agency, CA
Stefano A. Pileri, Bologna University School of Medicine, Bologna, IT
Diego Serraino, National Cancer Institute - Centro di Riferimento Oncologico, Aviano, IT
Mariagrazia Uguccioni, Institute for Research in Biomedicine, Bellinzona, CH


Lecturers Module 2

Berthe M.P. Aleman, The Netherlands Cancer Institute, Amsterdam, NL
James O. Armitage, University of Nebraska Medical Center, Omaha, NE,  US
Sally Barrington, PET Centre at St Thomas', Kings College London, London, UK
Nikolai C. Brun, Genmab A/S, Copenhagen, DK
Bruce D. Cheson, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, D.C., US
Daphne de Jong, VU University Medical Center, Amsterdam, NL
Kieron Dunleavy, National Cancer Institute, Bethesda, MD, US
Jonathan W. Friedberg, University of Rochester, James P. Wilmot Cancer Center, Rochester, NY, USA
Gerhard Held, Saarland University, Homburg, DE 
Peter Möller, University Hospital Ulm, Ulm, DE
Silvia Montoto, Barts Cancer Institute, London, UK
Jakob Passweg, University Hospital Basle, Basle, DE
Dietrich Rothenbacher
, Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, DE
Richard F. Schlenk, University Hospital Ulm, Ulm, DE
Alessandro Rambaldi, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, IT
Laurie H. Sehn, Centre for Lymphoid Cancer, BC Cancer Agency and the University of British Columbia, Vancouver, BC, CA
Margaret A. Shipp, Dana Farber Cancer Institute, Harvard Medical School, Boston, US
Anastasios Stathis, Clinical Research Unit, Oncology Institute of Southern Switzerland, Bellinzona, CH
Julie M. Vose, University of Nebraska Medical Center, Nebraska, US
Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, CH


Lecturers: Seminar 2

Lecturers to be confirmed


Lecturers: Module 3

James O. Armitage, University of Nebraska Medical Centre, Hematology-Oncology Section, Nebraska, US
Manuela Bergmann, Comprehensive Cancer Center Ulm, Ulm, DE
Franco Cavalli, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
Joseph M. Connors, British Columbia Cancer Agency, Vancouver, CA
Andrew Davies, University of Southampton School of Medicine, Somers Cancer Research Building, Southampton General Hospital, Southampton, UK
Angela Dispenzieri, Mayo Clinic, Division of Hematology, Department of Internal Medicine, Rochester, Minnesota, US
Martin Dreyling, Ludwig Maximilians-University München, University Hospital Großhadern, Dept. of Medicine, München, DE
Kieron Dunleavy, Center for Cancer Research, National Cancer Institute, Bethesda, MD, US
Andrés Ferreri, San Raffaele Scientific Institute, Milan, IT
Francesco Forconi, University of Southampton School of Medicine,  Somers Cancer Research Building, Southampton General Hospital, Southampton, UK 
Paolo Ghia, Università Vita - Salute San Raffaele, Medical School, Milano, IT
Michele Ghilemini, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
Christian Gisselbrecht, Hospital Saint Louis University Paris 7, Hemato-Oncology Department, Paris, FR
T. Andrew Lister, Barts Cancer Institute - a Cancer Research UK Centre of Excellence Queen Mary, University of London, London, UK
Werner Kempf, Medical School University of Zürich, Switzerland
Eva Kimby, Karolinska University Hospital, Hematology Center, M 54, Stockholm, SE
Ralf Kueppers, University of Duisburg-Essen, Essen, DE
Ian Magrath, International Network for Cancer Treatment and Research, Brussels, BE
Emili Montserrat, Hospital Clinic, University of Barcelona, Barcelona, ES
Antonio Palumbo, University of Turin, Dept. of Onco-Hematology, Turin, IT
Davide Rossi, Amedeo Avogadro University of Eastern Piedmont, Department of Haematology, Novara, IT
Gilles Salles, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Department of Hematology, Lyon, FR
Stephan Stilgenbauer, University of Ulm, Department  of Internal Medicine 3, Haematology and Oncology, Ulm, DE
Catherine Thieblemont, Hôpital Saint-Louis, Paris, FR


Lecturers: Module 4

Emilio Berti, University of Milan-Bicocca, Milan, IT
Bertrand Coiffier, Centre Hospitalier Lyon Sud, Pierre Bénite, FR
Claire Dearden, The Royal Marsden NHS Foundation Trust, Haemato-Oncology Unit & HMDS, London, UK
Dennis Eichenauer, University Clinic Cologne, Cologne, DE
Andrew Evens, Tufts University School of Medicine, Tufts Medical Center, Division of Hematology/Oncology, Boston, MA, US
Massimo Federico, Massimo Federico, University of Modena  and Reggio Emilia, Modena, IT
Andrés Ferreri, San Raffaele Scientific Institute, Milan, IT
Andrea Gallamini, S. Croce and Carle Hospital, Cuneo, IT
Won Seog Kim, Samsung Medical Center, Division of Hematology-Oncology, Seoul, KOR
Stefano Luminari, University of Modena and Reggio Emilia, Modena Oncology Centre, Dpt of Diagnostic, Clinical and Public Health Medicine, Modena, IT
Dror Meirow, Sheba Medical Center, Clinical Center for Fertility Preservation and the Fertility Preservation Research Laboratory aTel-Hashomer, Israel
Monika Metzger, St. Jude Children's Research Hospital, Dept. of Oncology,  Leukemia / Lymphoma Division, Memphis, TN, US
Fedro Peccatori, European Institute of Oncology, Fertility & Procreation Unit, Division of Gynecologic Oncology, Milan, IT
Ruth Pettengell, St George’s Hospital Medical School, Dept. of Haematology and Oncology, London, UK 
Stefano A. Pileri, Bologna University School of Medicine, Haematopathology Unit, Bologna, IT
Zbigniew Rudzki, Heartlands Hospital,  Department of Cellular Pathology, Birmingham, UK   
Stefano Sacchi, University of Modena and Reggio Emilia, Department of Oncology and Hematology, Modena, IT
John Sandlund, St. Jude Children's Research Hospital, Dept. of Oncology,  Leukemia / Lymphoma Division, Memphis, TN, US   
Kerry Savage, British Columbia Cancer Agency, Vancouver, CA
Bastian von Tresckow, University Clinic Cologne, Cologne, DE


Conceptual Development and Organisation

Uta Schmidt-Strassburger, Ulm, DE
Marcel Sailer, Soon Systems GmbH, Ulm, DE
Chatrina Melcher, ESO, Bellinzona, CH
Dolores Knupfer, ESO, Bellinzona, CH